1. Home
  2. MANH vs RGEN Comparison

MANH vs RGEN Comparison

Compare MANH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Associates Inc.

MANH

Manhattan Associates Inc.

HOLD

Current Price

$139.30

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$133.90

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MANH
RGEN
Founded
1990
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.1B
IPO Year
1998
1995

Fundamental Metrics

Financial Performance
Metric
MANH
RGEN
Price
$139.30
$133.90
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$220.42
$173.09
AVG Volume (30 Days)
1.0M
791.1K
Earning Date
04-28-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
2.56
N/A
EPS
3.60
0.63
Revenue
$131,300,000.00
$141,236,000.00
Revenue This Year
$8.10
$13.89
Revenue Next Year
$8.81
$15.00
P/E Ratio
$37.58
$209.75
Revenue Growth
N/A
35.10
52 Week Low
$127.86
$102.97
52 Week High
$247.22
$175.77

Technical Indicators

Market Signals
Indicator
MANH
RGEN
Relative Strength Index (RSI) 41.44 33.17
Support Level $136.61 $130.40
Resistance Level $180.67 $172.45
Average True Range (ATR) 6.04 7.43
MACD 0.29 -0.04
Stochastic Oscillator 37.74 52.71

Price Performance

Historical Comparison
MANH
RGEN

About MANH Manhattan Associates Inc.

Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers worldwide.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: